Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03930108
Other study ID # IndonesiaUAnes033
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 17, 2018
Est. completion date February 17, 2019

Study information

Verified date April 2019
Source Indonesia University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

SOFA score is valid for mortality predictor for critically-ill patient in high care and intensive care burn unit


Recruitment information / eligibility

Status Completed
Enrollment 169
Est. completion date February 17, 2019
Est. primary completion date December 17, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adult patients (age 18 and above) who admitted to burn unit during sampling period

Exclusion Criteria:

- patients discharged or deceased less than 24 hours of admission

- patients referred to other hospital within 30 days admission

Study Design


Related Conditions & MeSH terms


Intervention

Other:
SOFA score
Variables of sequential organ failure assessment score, including: P:F ratio; MAP or vasoactive treatment; creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS.

Locations

Country Name City State
Indonesia Rumah Sakit Cipto Mangunkusumo Jakarta Pusat DKI Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

References & Publications (22)

Andrias A, Hanafie A, Wijaya DW. Comparison of APACHE II, SOFA, and CSOFA Scoring System Validity as Mortality Predictor in ICU Patients in H. Adam Malik General Hospital. J Anestesi Perioper. 2017;5(1):17-23j.

Bouch DC, Thompson JP. Severity scoring systems in the critically ill. Contin Educ Anaesth Crit Care Pain. 2008;8(5):181-5.

Cabré L, Mancebo J, Solsona JF, Saura P, Gich I, Blanch L, Carrasco G, Martín MC; Bioethics Working Group of the SEMICYUC. Multicenter study of the multiple organ dysfunction syndrome in intensive care units: the usefulness of Sequential Organ Failure Assessment scores in decision making. Intensive Care Med. 2005 Jul;31(7):927-33. Epub 2005 Apr 26. — View Citation

Cárdenas-Turanzas M, Ensor J, Wakefield C, Zhang K, Wallace SK, Price KJ, Nates JL. Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care. 2012 Dec;27(6):673-80. doi: 10.1016/j.jcrc.2012.04.018. Epub 2012 Jul 2. — View Citation

Carson J, Goverman J, Fagan S. Acute renal failure in association with thermal injury. In: Herndon D, editor. Total Burn Care. 5th ed. Elsevier; 2018. p. 318-27.

de Brito MR, Barros AG, Valler L, Cardoso FB, Gasparotto AP, Tiziani L, et al. Evaluation of Sequential Organ Failure Assessment (SOFA) Performance in Neurocritical Care Patients Overtime: A Retrospective Cohort Study. J Brain Disord. 2017;1(1):38-43.

Emara SS, Alzaylai AA. Renal failure in burn patients: a review. Ann Burns Fire Disasters. 2013 Mar 31;26(1):12-5. — View Citation

Enkhbaatar P, Sousse L, Cox R, Herndon D. The pathophysiology of inhalation injury. In: Herndon D, editor. Total Burn Care. 5th ed. Elsevier; 2018. p. 174-83.

Guo F, Wang X, Huan J, Liang X, Chen B, Tang J, Gao C. Association of platelet counts decline and mortality in severely burnt patients. J Crit Care. 2012 Oct;27(5):529.e1-7. doi: 10.1016/j.jcrc.2011.12.006. Epub 2012 Feb 1. — View Citation

Ibrahim AE, Sarhane KA, Fagan SP, Goverman J. Renal dysfunction in burns: a review. Ann Burns Fire Disasters. 2013 Mar 31;26(1):16-25. — View Citation

Jain A, Palta S, Saroa R, Palta A, Sama S, Gombar S. Sequential organ failure assessment scoring and prediction of patient's outcome in Intensive Care Unit of a tertiary care hospital. J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):364-8. doi: 10.4103/0970-9185.168165. — View Citation

Karlie J, Wardhana A. External Validation of Belgian Outcome of Burn Injury Score on Burned Patient In Burn Unit Cipto Mangunkusumo General Hospital. New Ropanasuri J Surg. 2017;2(1):90.

Lorente JA, Vallejo A, Galeiras R, Tómicic V, Zamora J, Cerdá E, de la Cal MA, Esteban A. Organ dysfunction as estimated by the sequential organ failure assessment score is related to outcome in critically ill burn patients. Shock. 2009 Feb;31(2):125-31. doi: 10.1097/SHK.0b013e31817fc3ef. — View Citation

Marck RE, Montagne HL, Tuinebreijer WE, Breederveld RS. Time course of thrombocytes in burn patients and its predictive value for outcome. Burns. 2013 Jun;39(4):714-22. doi: 10.1016/j.burns.2013.01.015. Epub 2013 Mar 13. — View Citation

Nair R, Bhandary NM, D'Souza AD. Initial Sequential Organ Failure Assessment score versus Simplified Acute Physiology score to analyze multiple organ dysfunction in infectious diseases in Intensive Care Unit. Indian J Crit Care Med. 2016 Apr;20(4):210-5. doi: 10.4103/0972-5229.180041. — View Citation

Nielson CB, Duethman NC, Howard JM, Moncure M, Wood JG. Burns: Pathophysiology of Systemic Complications and Current Management. J Burn Care Res. 2017 Jan/Feb;38(1):e469-e481. doi: 10.1097/BCR.0000000000000355. Review. — View Citation

Queiroz LF, Anami EH, Zampar EF, Tanita MT, Cardoso LT, Grion CM. Epidemiology and outcome analysis of burn patients admitted to an Intensive Care Unit in a University Hospital. Burns. 2016 May;42(3):655-62. doi: 10.1016/j.burns.2015.08.002. Epub 2016 Jan 4. — View Citation

Snell JA, Loh NH, Mahambrey T, Shokrollahi K. Clinical review: the critical care management of the burn patient. Crit Care. 2013 Oct 7;17(5):241. doi: 10.1186/cc12706. Review. — View Citation

Sunaryo A, Redjeki IS, Bisri T. Perbandingan Validasi APACHE II dan SOFA Score untuk Memperkirakan Mortalitas Pasien yang Dirawat di Ruang Perawatan Intensif. Majalah Kedokteran Terapi Intensif. 2012;2(1):11-20.

Taofik S, Senapathi TGA, Wiryana M. Comparison Of Validity Apache II, SOFA And Customized Sequential Organ Failure Assessment (Csofa) For Predicting Non-Surgical Patient. J Anestesiol Indones. 2015;7(2):102-13.

Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998 Nov;26(11):1793-800. — View Citation

Wardhana A, Basuki A, Prameswara ADH, Rizkita DN, Andarie AA, Canintika AF. The epidemiology of burns in Indonesia's national referral burn center from 2013 to 2015. Burn Open. 2017;1(2):67-73.

* Note: There are 22 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary SOFA score Discrimination SOFA score ability to discriminate outcomes based on variable scores: PaO2/FiO2; MAP/vasoactive treatment; serum creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS 30 days from admission
Primary SOFA score Calibration SOFA score cutoff to predict outcome based on variable scores: PaO2/FiO2; MAP/vasoactive treatment; serum creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS 30 days from admission
Primary Correlation between SOFA score variables with outcome Correlation between patient outcomes with each SOFA score variable: PaO2/FiO2; MAP/vasoactive treatment; serum creatinine or 24-h diuresis; platelet count; serum bilirubin; GCS 30 days from admission
Secondary Patient outcome Patient outcome within 30 days of admission to burn units: deceased or survived 30 days from admission
Secondary SOFA score: Partial Oxygen Pressure (PaO2)/ Fraction of Inspired Oxygen (FiO2) The score for PaO2/FiO2 variable cutoff:
0 point for >400 mmHg;
point for <400 mmHg;
points for <300 mmHg;
points for <200 mmHg with respiratory support;
points for <100 mmHg with respiratory support.
Day 1
Secondary SOFA score: Mean Arterial Pressure (MAP) or vasoactive agent usage The score for MAP or vasoactive agent usage variable cutoff:
0 point for MAP >=70 mmHg;
point for MAP <70 mmHg;
points for dopamine <= 5 mcg/kg/min OR dobutamine any dose;
points for dopamine >5 mcg/kg/min OR norepinephrine or epinephrine <=0.1 mcg/kg/min;
points for dopamine >15 mcg/kg/min OR norepinephrine or epinephrine >0.1 mcg/kg/min.
Day 1
Secondary SOFA score: Serum creatinine or 24-hour diuresis The score for serum creatinine or 24-hour diuresis variable cutoff:
0 point for creatinine <1.2 mg/dL;
point for creatinine 1.2 - 1.9 mg/dL;
points for creatinine 2.0 - 3.4 mg/dL;
points for creatinine 3.5 - 4.9 mg/dL OR diuresis <500 mL/24h;
points for creatinine >5.0 mg/dL OR diuresis <200 mL/24h.
Day 1
Secondary SOFA score: Platelet count The score for platelet count variable cutoff:
0 point for >=150 x10^3/mm^3;
point for <150 x10^3/mm^3;
points for <100 x10^3/mm^3;
points for <50 x10^3/mm^3;
points for <20 x10^3/mm^3.
Day 1
Secondary SOFA score: Serum Bilirubin The score for serum bilirubin variable cutoff:
0 point for <1.2 mg/dL;
point for 1.2 - 1.9 mg/dL;
points for 2.0 - 5.9 mg/dL;
points for 6.0 - 11.9 mg/dL;
points for >12.0 mg/dL.
Day 1
Secondary SOFA score: Glasgow Coma Scale (GCS) The score for GCS variable cutoff:
0 point for 15;
point for 13 - 14;
points for 10 - 12;
points for 6 - 9;
points for <6L.
Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT06163976 - Prognostic Modelling for Prediction of Mortality and Functional Disability in Critically-ill Elderly Patients